000 01500 a2200421 4500
005 20250517060845.0
264 0 _c20160616
008 201606s 0 0 eng d
022 _a1479-5876
024 7 _a10.1186/s12967-015-0698-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYang, Rachel L
245 0 0 _aDCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3.
_h[electronic resource]
260 _bJournal of translational medicine
_cOct 2015
300 _a335 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aCarcinoma, Intraductal, Noninfiltrating
_xgenetics
650 0 4 _aFemale
650 0 4 _aGenes, BRCA1
650 0 4 _aGenes, BRCA2
650 0 4 _aGenetic Carrier Screening
650 0 4 _aHumans
650 0 4 _aMutation
650 0 4 _aPhenotype
650 0 4 _aReceptor Protein-Tyrosine Kinases
_xgenetics
650 0 4 _aReceptor, ErbB-3
_xgenetics
700 1 _aMick, Rosemarie
700 1 _aLee, Kathreen
700 1 _aGraves, Holly L
700 1 _aNathanson, Katherine L
700 1 _aDomchek, Susan M
700 1 _aKelz, Rachel R
700 1 _aZhang, Paul J
700 1 _aCzerniecki, Brian J
773 0 _tJournal of translational medicine
_gvol. 13
_gp. 335
856 4 0 _uhttps://doi.org/10.1186/s12967-015-0698-3
_zAvailable from publisher's website
999 _c25382987
_d25382987